SLDB - Solid Biosciences Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development57,96539,90520,1164,192
Selling General and Administrative17,72214,9525,4602,372
Non Recurring----
Others----
Total Operating Expenses75,68754,85725,5766,564
Operating Income or Loss-75,687-54,857-25,576-6,564
Income from Continuing Operations
Total Other Income/Expenses Net8891,6791,803-100
Earnings Before Interest and Taxes-75,687-54,857-25,576-6,564
Interest Expense----
Income Before Tax-74,798-53,178-23,773-6,664
Income Tax Expense----
Minority Interest--46,47447,588
Net Income From Continuing Ops-74,798-53,178-23,773-6,664
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-74,798-52,118-21,539-6,377
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-74,798-39,317-17,230-6,445